A decomposable silica-based antibacterial coating for percutaneous titanium implant

International Journal of Nanomedicine

Volumn 12, Issue , 2017, Pages 371-379

  Wang, Jia ^a   Wu, Guofeng ^b   Liu, Xiangwei ^a   Sun, Guanyang ^a   Li, Dehua ^a   Wei, Hongbo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Control release; Fibroblasts; Gentamycin; Microarc oxidation; Silica nanoparticles

Indexed keywords

GELATIN; GENTAMICIN; SILICA NANOPARTICLE; ANTIINFECTIVE AGENT; BIOCOMPATIBLE COATED MATERIAL; NANOPARTICLE; SILICON DIOXIDE; TITANIUM;

ARTICLE; BACTERIAL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY TEST; DECOMPOSITION; DRUG COATING; DRUG STRUCTURE; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; ZETA POTENTIAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; DRUG RELEASE; MICROBIAL SENSITIVITY TEST; PROSTHESES AND ORTHOSES; STAPHYLOCOCCAL INFECTIONS; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; CELL DEATH; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DRUG LIBERATION; FIBROBLASTS; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PROSTHESES AND IMPLANTS; SILICON DIOXIDE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES; TITANIUM;

EID: 85010070447     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S123622     Document Type: Article

References (37)

1. Gitto CA, Plata WG, Schaaf NG. Evaluation of the peri-implant epithelial tissue of percutaneous implant abutments supporting maxillofacial prostheses. Int J Oral Maxillofac Implants. 1994;9(2):197–206.
2. Pekkan G, Tuna SH, Oghan F. Extraoral prostheses using extraoral implants. Int J Oral Maxillofac Surg. 2011;40(4):378–383.
3. Leonardi A, Buonaccorsi S, Pellacchia V, Moricca LM, Indrizzi E, Fini G. Maxillofacial prosthetic rehabilitation using extraoral implants. J Craniofac Surg. 2008;19(2):398–405.
4. Visser A, Raghoebar GM, van Oort RP, Vissink A. Fate of implant-retained craniofacial prostheses: life span and aftercare. Int J Oral Maxillofac Implants. 2008;23(1):89–98.
5. Karakoca S, Aydin C, Yilmaz H, Bal BT. Retrospective study of treatment outcomes with implant-retained extraoral prostheses: survival rates and prosthetic complications. J Prosthet Dent. 2010;103(2):118–126.
6. Roumanas ED, Freymiller EG, Chang TL, Aghaloo T, Beumer J 3rd. Implant-retained prostheses for facial defects: an up to 14-year follow-up report on the survival rates of implants at UCLA. Int J Prosthodont. 2002;15(4):325–332.
7. Curi MM, Oliveira MF, Molina G, et al. Extraoral implants in the rehabilitation of craniofacial defects: implant and prosthesis survival rates and peri-implant soft tissue evaluation. J Oral Maxillofac Surg. 2012;70(7):1551–1557.
8. Miles BA, Sinn DP, Gion GG. Experience with cranial implant-based prosthetic reconstruction. J Craniofac Surg. 2006;17(5):889–897.
9. Karakoca S, Aydin C, Yilmaz H, Bal BT. Survival rates and periimplant soft tissue evaluation of extraoral implants over a mean follow-up period of three years. J Prosthet Dent. 2008;100(6):458–464.
10. Jansen JA, van der Waerden JP, de Groot K. Epithelial reaction to percutaneous implant materials: in vitro and in vivo experiments. J Invest Surg. 1989;2(1):29–49.
11. Jansen JA, van der Waerden JP, de Groot K. Fibroblast and epithelial cell interactions with surface-treated implant materials. Biomaterials. 1991;12(1):25–31.
12. Holt BM, Betz DH, Ford TA, Beck JP, Bloebaum RD, Jeyapalina S. Pig dorsum model for examining impaired wound healing at the skin-implant interface of percutaneous devices. J Mater Sci Mater Med. 2013;24(9):2181–2193.
13. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422–1429.
14. Vester H, Wildemann B, Schmidmaier G, Stöckle U, Lucke M. Gentamycin delivered from a PDLLA coating of metallic implants: in vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Injury. 2010;41(10):1053–1059.
15. de Breij A, Riool M, Kwakman PH, et al. Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145. J Control Release. 2016;222:1–8.
16. Choe H, Narayanan AS, Gandhi DA, et al. Immunomodulatory peptide IDR-1018 decreases implant infection and preserves osseointegration. Clin Orthop Relat Res. 2015;473(9):2898–2907.
17. Calliess T, Sluszniak M, Winkel A, et al. Antimicrobial surface coatings for a permanent percutaneous passage in the concept of osseointegrated extremity prosthesis. Biomed Tech (Berl). 2012;57(6):467–471.
18. Mei S, Wang H, Wang W, et al. Antibacterial effects and biocompatibility of titanium surfaces with graded silver incorporation in titania nanotubes. Biomaterials. 2014;35(14):4255–4265.
19. Abdulkareem EH, Memarzadeh K, Allaker RP, Huang J, Pratten J, Spratt D. Anti-biofilm activity of zinc oxide and hydroxyapatite nanoparticles as dental implant coating materials. J Dent. 2015;43(12):1462–1469.
20. Elizabeth E, Baranwal G, Krishnan AG, Menon D, Nair M. ZnO nanoparticle incorporated nanostructured metallic titanium for increased mesenchymal stem cell response and antibacterial activity. Nanotechnology. 2014;25(11):337–345.
21. Chen R, Willcox MD, Ho KK, Smyth D, Kumar N. Antimicrobial peptide melimine coating for titanium and its in vivo antibacterial activity in rodent subcutaneous infection models. Biomaterials. 2016;85:142–151.
22. 2-Ag antibacterial coatings for human fetal osteoblasts. Acta Biomater. 2012;8(11):4191–4197.
23. Yildirim A, Ozgur E, Bayindir M. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. J Mater Chem B. 2013;1(14):1909–1920.
24. Sripanyakorn S, Jugdaohsingh R, Dissayabutr W, Anderson SH, Thompson RP, Powell JJ. The comparative absorption of silicon from different foods and food supplements. Brit J Nutr. 2009;102(6):825–834.
25. Fan L, Jin B, Zhang S, Song C, Li Q. Stimuli-free programmable drug release for combination chemo-therapy. Nanoscale. 2016;8(25):12553–12559.
26. Fan L, Zhang Y, Wang F, et al. Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs. Biomaterials. 2016;76:399–407.
27. 2 nanoparticles for sustained drug release. Nanoscale. 2015;7(39):16389–16398.
28. Wei D, Zhou Y, Jia D, Wang Y. Characteristic and in vitro bioactivity of a microarc-oxidized TiO(2)-based coating after chemical treatment. Acta Biomater. 2007;3(5):817–827.
29. 2-drug composite nanoparticles. J Am Chem Soc. 2013;135(15):5709–5716.
30. Cheng Y, Wu J, Gao B, et al. Fabrication and in vitro release behavior of a novel antibacterial coating containing halogenated furanone-loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium. Int J Nanomed. 2011;7(6):5641–5652.
31. El-Ghalbzouri A, Van Den Bogaerdt AJ, Kempenaar J, Ponec M. Human adipose tissue-derived cells delay re-epithelialization in comparison with skin fibroblasts in organotypic skin culture. Br J Dermatol. 2004;150(3):444–454.
32. Isackson D, McGill LD, Bachus KN. Percutaneous implants with porous titanium dermal barriers: an in vivo evaluation of infection risk. Med Eng Phys. 2011;33(33):418–426.
33. Actis L, Gaviria L, Guda T, Ong JL. Antimicrobial surfaces for craniofacial implants: state of the art. J Korean Assoc Oral Maxillofac Surg. 2013;39(39):43–54.
34. Izquierdo-Barba I, Vallet-Regí M, Kupferschmidt N, Terasaki O, Schmidtchen A, Malmsten M. Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials. 2009;30(29):5729–5736.
35. Vasilev K, Cook J, Griesser HJ. Antibacterial surfaces for biomedical devices. Expert Rev Med Devices. 2009;6(5):553–567.
36. Swartjes JJ, Sharma PK, van Kooten TG, et al. Current developments in antimicrobial surface coatings for biomedical applications. Curr Med Chem. 2015;22(18):2116–2129.
37. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322.